Related Experiment Videos
GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which
Kathy Triantafilou1, Didier Fradelizi, Keith Wilson
1School of Biological Sciences, University of Portsmouth, Portsmouth PO1 2DY, United Kingdom.
Journal of Virology
|December 26, 2001
Summary
Coxsackievirus A9 (CAV-9) uses integrin alpha(v)beta3 and GRP78 as cell surface receptors for entry. Major histocompatibility complex class I (MHC-I) molecules facilitate CAV-9 internalization into mammalian cells.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Viruses utilize specific cell surface molecules for attachment and entry, often involving multistep processes.
- Coxsackievirus A9 (CAV-9) infection requires integrin alpha(v)beta3 as a receptor and a 70-kDa protein (MAP-70) as a coreceptor.
- The precise roles of these molecules in CAV-9 entry remain to be fully elucidated.
Purpose of the Study:
- To investigate the attachment and entry pathway of Coxsackievirus A9 (CAV-9).
- To identify the 70-kDa major histocompatibility complex class I (MHC-I)-associated protein (MAP-70) involved in CAV-9 infection.
- To elucidate the functional association between GRP78, MHC-I, and CAV-9 entry.
Main Methods:
- Protein isolation and peptide sequencing to identify the 70-kDa protein.
- Fluorescence resonance energy transfer (FRET) to study molecular interactions.
- Assessing the requirement of GRP78 and MHC-I for CAV-9 infection and internalization.
Main Results:
- The 70-kDa protein was identified as GRP78, a heat shock protein 70 family member.
- GRP78 is expressed on the cell surface and associates with MHC-I molecules.
- CAV-9 infection necessitates GRP78 and MHC-I for efficient internalization into permissive cells.
Conclusions:
- GRP78 functions as a coreceptor for CAV-9, alongside integrin alpha(v)beta3 as the primary receptor.
- MHC-I molecules are essential for the internalization pathway of CAV-9 into mammalian cells.
- This study provides new insights into the CAV-9 life cycle, highlighting the roles of GRP78 and MHC-I in viral entry.